Tislelizumab is under clinical development by BeiGene and currently in Pre-Registration for Esophageal Squamous Cell Carcinoma (ESCC).
CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Disease
BOSTON — Some of the latest research advancements in the field of pulmonology presented at the CHEST 2024 annual meeting, hosted by the American College